(NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, said ...
Morning Overview on MSN
A new antiviral is cleared for herpes sores that standard drugs failed to heal in immunocompromised adults
Pritelivir, sold as Hovilpri, won U.S. approval on October 9, 2026 for one narrow job: clearing mucocutaneous herpes simplex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results